1 Market Overview
1.1 Product Overview and Scope of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2
1.2 Classification of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Type
1.2.1 Overview: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Type in 2020
1.2.3 EL-001
1.2.4 LASSBio-785
1.2.5 LASSBio-786
1.2.6 Midazolam Hydrochloride
1.2.7 Others
1.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Application
1.3.1 Overview: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 General Anesthetic Effect
1.3.3 Insomnia
1.3.4 Hypertension
1.3.5 Others
1.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size & Forecast
1.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast by Region
1.5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region, (2016-2021)
1.5.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.4 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.6 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Drivers
1.6.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Restraints
1.6.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Trends Analysis
2 Company Profiles
2.1 Jiangsu Hengrui Medicine Co Ltd
2.1.1 Jiangsu Hengrui Medicine Co Ltd Details
2.1.2 Jiangsu Hengrui Medicine Co Ltd Major Business
2.1.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.1.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments and Future Plans
2.2 Jiangsu Nhwa Pharmaceutical Corp Ltd
2.2.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Details
2.2.2 Jiangsu Nhwa Pharmaceutical Corp Ltd Major Business
2.2.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.2.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Developments and Future Plans
2.3 Paion AG
2.3.1 Paion AG Details
2.3.2 Paion AG Major Business
2.3.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.3.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Paion AG Recent Developments and Future Plans
2.4 Pfizer Inc
2.4.1 Pfizer Inc Details
2.4.2 Pfizer Inc Major Business
2.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Inc Recent Developments and Future Plans
2.5 Primex Pharmaceuticals Oy
2.5.1 Primex Pharmaceuticals Oy Details
2.5.2 Primex Pharmaceuticals Oy Major Business
2.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Primex Pharmaceuticals Oy Recent Developments and Future Plans
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business
2.6.3 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product and Solutions
2.6.4 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Market Share
3.2.2 Top 10 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Market Share
3.2.3 Market Competition Trend
3.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Market Share by Type (2016-2021)
4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Market Share by Application (2016-2021)
5.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
6.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
6.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
6.3.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
6.3.2 United States Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
6.3.3 Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
6.3.4 Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
7.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
7.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
7.3.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
7.3.2 Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.3 France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.5 Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
7.3.6 Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
8.2 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
8.3 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region
8.3.1 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Region (2016-2026)
8.3.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.3 Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.4 South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.5 India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
8.3.7 Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
9.2 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
9.3 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
9.3.1 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
9.3.2 Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
9.3.3 Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Type (2016-2026)
10.2 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Application (2016-2026)
10.3 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
10.3.1 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Country (2016-2026)
10.3.2 Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
10.3.4 UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Jiangsu Hengrui Medicine Co Ltd、Jiangsu Nhwa Pharmaceutical Corp Ltd、Paion AG、Pfizer Inc、Primex Pharmaceuticals Oy、Takeda
【免責事項】
https://www.globalresearch.jp/disclaimer